Who founded Matrisome Bio?

Matrisome Bio was founded by Noor Jailkhani, Richard Hynes, Sangeeta Bhatia.

Who are Matrisome Bio's investors?

Matrisome Bio's investors include Bold Capital Partners, The Engine Ventures.

Matrisome Bio

10 employees on LinkedIn · 2 known investors

Find your way into Matrisome Bio

Each arrow is one introduction. Sign up to fill in the first one.

1,206 people can intro you to Sangeeta

Ask Stan Lapidus to introduce you to Sangeeta N. Bhatia

You →Stan · together at Amplifyer Bio →Sangeeta

465 people can intro you to Edward

Ask Jamie Chen to introduce you to Edward Tad Stewart

You →Jamie · together at Crescendo Biologics →Edward

122 people can intro you to Monica

Ask Sam Okafor to introduce you to Monica Gostissa

You →Sam · together at Egle Therapeutics →Monica

Your email: who you already know at Matrisome Bio, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Matrisome Bio team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Matrisome Bio is an oncology biotech developing therapies based on extracellular matrix (ECM) biology, using a protein engineering platform to target the tumor microenvironment. Its work spans multiple modalities including radioligand therapies.

Biotech Deep Tech Healthtech

Founders & leadership

Noor JailkhaniCo-Founder and CEO

Richard HynesCo-Founder / Professor, MIT & HHMI

Sangeeta Bhatia Co-Founder / Professor, MIT & HHMIVenture Partner at Catalio Capital Management, LP

Monica Gostissa Chief Science OfficerChief Science Officer at Matrisome Bio, an oncology biotech developing extracellular matrix-targeted therapies. Gostissa has extensive background in R&D and drug discovery, including immunology, and has progressed programs through IND submission.

Edward Tad Stewart Chief Business OfficerEdward Tad Stewart is Chief Business Officer of Matrisome Bio, a biotech company developing extracellular matrix-based oncology therapies. He brings over two decades of experience in biotech business development, fundraising, and operations across the product development lifecycle.

Investors · 2

Bold Capital Partnerslisted by Bold Capital PartnersSanta Monica

How we know: Bold Capital Partners's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

The Engine Ventureslisted by The Engine VenturesCambridge

How we know: the VCSheet dataset · Not right? Tell us

Founder mafia

2 people who came through Matrisome Bio went on to found or lead other companies.

Sangeeta N. BhatiaCo-Founder / Professor, MIT & HHMIFounded Satellite Bio +3 Edward Tad StewartChief Business OfficerFounded Innovative Health Solutions

Frequently asked questions

What does Matrisome Bio do?: Matrisome Bio is an oncology biotech developing therapies based on extracellular matrix (ECM) biology, using a protein engineering platform to target the tumor microenvironment. Its work spans multiple modalities including radioligand therapies.
Who founded Matrisome Bio?: Matrisome Bio was founded by Noor Jailkhani, Richard Hynes, Sangeeta Bhatia.
Who are Matrisome Bio's investors?: Matrisome Bio's investors include Bold Capital Partners, The Engine Ventures.